Amgen is committed to fostering trust between industry, healthcare professionals and patients.
Amgen contributes to the quality use of medicines in Australia through the provision of education, sponsorship and support of healthcare professionals to attend educational and scientific meetings.
In line with community expectations, Amgen provides public disclosure of these interactions.
As a member of Medicines Australia, Amgen Australia Pty Ltd has undertaken to be open and transparent when we provide a reportable payment or transfer of value to a healthcare professional.
Reportable payments or transfers of value are:
Amgen Australia has prepared these reports for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy legislation. The reports identify healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.
From 1 October 2016, reporting these payments became mandatory – details are reported because healthcare professionals should reasonably expect that all reportable payments or transfers of value will be disclosed for each healthcare professional, by name.
From 30 August 2019, this information will now be held in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file.
The reports for transfers of value made will be available for three years from the date of publication.
The reports prior to 30 August are designed to be read on this website and are also provided as downloadable CSV files. To comply with our privacy obligations, the reports may be amended from time to time. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.